CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $254K invested in Can-Fite BioPharma in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$101K
2
+$48K

Top Sellers

1
-$610K
2
-$103K
3
-$37K
4
Morgan Stanley
Morgan Stanley
New York
-$21.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$104K
2
$101K
3
$48K
4
$1.1K
5
–
6
–
7
–